Jeffrey E. Russel

Array ( [id] => 7540551 [patent_doc_number] => 08058394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Method for production of peptide thioester compound' [patent_app_type] => utility [patent_app_number] => 12/295113 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9576 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058394.pdf [firstpage_image] =>[orig_patent_app_number] => 12295113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063586 [patent_doc_number] => 20070225226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'C-REACTIVE PROTEIN APHERESIS' [patent_app_type] => utility [patent_app_number] => 11/690318 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6976 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225226.pdf [firstpage_image] =>[orig_patent_app_number] => 11690318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225572 [patent_doc_number] => 20070254839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/689037 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25315 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254839.pdf [firstpage_image] =>[orig_patent_app_number] => 11689037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7595457 [patent_doc_number] => 07626004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Protein purification' [patent_app_type] => utility [patent_app_number] => 11/717510 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 8143 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/626/07626004.pdf [firstpage_image] =>[orig_patent_app_number] => 11717510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879229 [patent_doc_number] => 20080152612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Peptide-based conditioners and colorants for hair, skin, and nails' [patent_app_type] => utility [patent_app_number] => 11/716161 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24828 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152612.pdf [firstpage_image] =>[orig_patent_app_number] => 11716161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199691 [patent_doc_number] => 20070299009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'ANALOGS OF PARATHYROID HORMONE' [patent_app_type] => utility [patent_app_number] => 11/684383 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16078 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299009.pdf [firstpage_image] =>[orig_patent_app_number] => 11684383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 295751 [patent_doc_number] => 07541018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Treatment process using somatostatin analogues' [patent_app_type] => utility [patent_app_number] => 11/683734 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4824 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541018.pdf [firstpage_image] =>[orig_patent_app_number] => 11683734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580063 [patent_doc_number] => 07452860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Zinc-free and low-zinc insulin preparations having improved stability' [patent_app_type] => utility [patent_app_number] => 11/683747 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5873 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452860.pdf [firstpage_image] =>[orig_patent_app_number] => 11683747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23882 [patent_doc_number] => 07795226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Control of radiation injury' [patent_app_type] => utility [patent_app_number] => 11/715314 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23723 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795226.pdf [firstpage_image] =>[orig_patent_app_number] => 11715314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189061 [patent_doc_number] => 20070167370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Peptide analogues of GIP for treatment of diapetes, insulin resistance and obesity' [patent_app_type] => utility [patent_app_number] => 11/713892 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 28094 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167370.pdf [firstpage_image] =>[orig_patent_app_number] => 11713892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7539968 [patent_doc_number] => 08057810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application' [patent_app_type] => utility [patent_app_number] => 12/298423 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8208 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/057/08057810.pdf [firstpage_image] =>[orig_patent_app_number] => 12298423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252802 [patent_doc_number] => 07579436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Peptide compound for measuring sulfur compound and ammonia' [patent_app_type] => utility [patent_app_number] => 11/681094 [patent_app_country] => US [patent_app_date] => 2007-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2459 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579436.pdf [firstpage_image] =>[orig_patent_app_number] => 11681094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225594 [patent_doc_number] => 20070254861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Methods for the prevention and/or treatment of peripheral arterial disease' [patent_app_type] => utility [patent_app_number] => 11/712397 [patent_app_country] => US [patent_app_date] => 2007-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4698 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254861.pdf [firstpage_image] =>[orig_patent_app_number] => 11712397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380244 [patent_doc_number] => 20090192083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/280374 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 226 [patent_figures_cnt] => 226 [patent_no_of_words] => 79652 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12280374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496360 [patent_doc_number] => 20090264388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Compounds and Methods of Treating Disorders Associated With Activation of Metachromatic Cells' [patent_app_type] => utility [patent_app_number] => 12/224279 [patent_app_country] => US [patent_app_date] => 2007-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16675 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264388.pdf [firstpage_image] =>[orig_patent_app_number] => 12224279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552431 [patent_doc_number] => 08759483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'HLA-A* 3303-restricted WT1 peptide and pharmaceutical composition comprising the same' [patent_app_type] => utility [patent_app_number] => 12/280268 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6671 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12280268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368400 [patent_doc_number] => 20090305959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Use of Peptidic Vasopressin Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 12/223673 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5414 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305959.pdf [firstpage_image] =>[orig_patent_app_number] => 12223673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772611 [patent_doc_number] => 20080058270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders' [patent_app_type] => utility [patent_app_number] => 11/704871 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36012 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058270.pdf [firstpage_image] =>[orig_patent_app_number] => 11704871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687785 [patent_doc_number] => 20080031966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Sustained release compositions for delivery of pharmaceutical proteins' [patent_app_type] => utility [patent_app_number] => 11/703553 [patent_app_country] => US [patent_app_date] => 2007-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10298 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031966.pdf [firstpage_image] =>[orig_patent_app_number] => 11703553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8188914 [patent_doc_number] => 08183055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same' [patent_app_type] => utility [patent_app_number] => 12/278475 [patent_app_country] => US [patent_app_date] => 2007-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 6408 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183055.pdf [firstpage_image] =>[orig_patent_app_number] => 12278475 [rel_patent_id] =>[rel_patent_doc_number] =>)